Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Enzyme Inhibition
  4. Fast Track Articles
  5. Fast Track Article
image of In vitro and In Silico Molecular Modeling Studies of Newly Synthesized Pyrrole Derivatives for their Antimicrobial and Anticancer Properties

Abstract

Background

Pyrroles are biologically active scaffolds that can have a number of different effects. They also have unique pharmacophores inside their ring system that make it easier to make molecules that are more active. Significantly, in the past ten years, research has been conducted on the anti-bacterial properties, with a particular emphasis on drug-resistant Gram-positive and Gram-negative pathogens such as mycobacteria. Additionally, scaffolds based on pyrroles were utilized in the production of anti-tumor medicines that function by modulating or suppressing genes.

Objective

This research aimed to create new pyrrole derivatives by chemical means and evaluate their antimicrobial and anticancer properties.

Methods

By reacting diverse 1H-pyrrole-2-carbohydrazide derivatives with benzaldehyde under normal conditions, a number of pyrrole variations were created. IR, mass spectroscopy, NMR, and elemental analysis were used to characterize the synthesized compounds. The serial dilution method was used to assess antimicrobial activity, along with a molecular docking study against the enzyme α-topoisomerase II (α-Topo II), which effectively controls the topology of DNA. This enzyme is strongly expressed in rapidly dividing cells and is crucial for transcription, replication, and chromosome structure. Pyrrole and its synthetic derivatives are known to exhibit strong anticancer activity by specifically targeting α-Topo II, which has led multiple researchers to investigate α-Topo II inhibitors as potential anticancer medicines. Consequently, designing pyrroline derivatives is interesting since the succinimide portion of the joined heteroaromatic molecule can selectively engage with the ATP binding pocket the hydrogen bond network. Newer synthesized compounds were also docked Schrodinger 2022-4 into the active pocket of the three-dimensional crystallographic structure of the ATP site of human topoisomerase IIα (htopo IIα) (PDB ID: 1zxm).

Results

Among the newly synthesized pyrrole derivatives, compounds demonstrated significant anti-microbial activity. In addition, the AutoDock Vina application was used to perform docking computations. Compounds and were found to have a stronger antiproliferative effect than compounds against MCF-07 breast cancer cell linen our study, ligands 1a and 1b exhibited better binding energies of -5.049 and -5.035 kcal/mol, respectively. Most of the synthesized pyrrole derivatives showed promising antiproliferative effects; however, further investigations are needed to confirm or refute these results.

Conclusion

The results of this investigation show that pyrrole derivatives have the potential to be effective antimicrobial and anticancer agents. While resolving safety issues, the structural alterations carried out in this study enhanced the compounds' medicinal capabilities. To clarify the underlying mechanisms of action and enhance the pharmacological characteristics of these new pyrrole derivatives, further research is necessary.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cei/10.2174/0115734080340941241002051637
2024-10-22
2024-11-16

  • From This Site

    /content/journals/cei/10.2174/0115734080340941241002051637
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Gholap S.S. Pyrrole: An emerging scaffold for construction of valuable therapeutic agents. Eur. J. Med. Chem. 2016 110 13 31 10.1016/j.ejmech.2015.12.017 26807541
    [Google Scholar]
  2. Ali I. Lone M. Al-Othman Z. Al-Warthan A. Sanagi M. Heterocyclic scaffolds: Centrality in anticancer drug development. Curr. Drug Targets 2015 16 7 711 734 10.2174/1389450116666150309115922 25751009
    [Google Scholar]
  3. Ali I. Lone M.N. Alothman Z.A. Alwarthan A. Insights into the pharmacology of new heterocycles embedded with oxopyrrolidine rings: DNA binding, molecular docking, and anticancer studies. J. Mol. Liq. 2017 234 391 402 10.1016/j.molliq.2017.03.112
    [Google Scholar]
  4. Katritzky A.R. Rees C.W. Comprehensive Heterocyclic Chemistry II. Oxford Pergamon 1996 3 4
    [Google Scholar]
  5. Marc G. Chemistry of Naphthalene and the Aromatic Heterocycles, Organic Chemistry fourth ed. Oxford University Press: New York 2000
    [Google Scholar]
  6. Michael C. Lehniger A.L. Nelson D.R. Lehniger Principles of Biochemistry. New York Worth Publisher 2000
    [Google Scholar]
  7. Juse´lius J. Sundholm D. The aromatic pathways of porphins, chlorins and bacteriochlorins. Phys. Chem. Chem. Phys. 2000 2 10 2145 2151 10.1039/b000260g
    [Google Scholar]
  8. Domagala A. Jarosz T. Lapkowski M. Living on pyrrolic foundations e Advances in natural and artificial bioactive pyrrole derivatives. Eur. J. Med. Chem. 1787 2015 100 1760e
    [Google Scholar]
  9. Jones R.A. Pyrroles: the Synthesis and the Physical and Chemical Aspects of the Pyrrole Ring. Wiley-Interscience 1990
    [Google Scholar]
  10. Nakano H. Umio S. Kariyone K. Tanaka K. Kishimoto T. Noguchi H. Ueda I. Nakamura H. Morimoto T. Total synthesis of pyrrolnitrin, a new antibiotic. Tetrahedron Lett. 1966 7 7 737 740 10.1016/S0040‑4039(00)90255‑7 5955096
    [Google Scholar]
  11. Wilkerson W.W. Copeland R.A. Covington M. Trzaskos J.M. Antiinflammatory 4,5-diarylpyrroles. 2. Activity as a function of cyclooxygenase-2 inhibition. J. Med. Chem. 1995 38 20 3895 3901 10.1021/jm00020a002 7562922
    [Google Scholar]
  12. Wurz R.P. Charette A.B. Doubly activated cyclopropanes as synthetic precursors for the preparation of 4-nitro- and 4-cyano-dihydropyrroles and pyrroles. Org. Lett. 2005 7 12 2313 2316 10.1021/ol050442l 15932186
    [Google Scholar]
  13. Lee H. Lee J. Lee S. Shin Y. Jung W. Kim J.H. Park K. Kim K. Cho H.S. Ro S. Lee S. Jeong S. Choi T. Chung H.H. Koh J.S. A novel class of highly potent, selective, and non-peptidic inhibitor of ras farnesyltransferase (FTase). Bioorg. Med. Chem. Lett. 2001 11 23 3069 3072 10.1016/S0960‑894X(01)00624‑2 11714612
    [Google Scholar]
  14. Pullar I.A. Carney S.L. Colvin E.M. Lucaites V.L. Nelson D.L. Wedley S. LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine2A receptor antagonist: a comparison with the antidepressant, nefazodone. Eur. J. Pharmacol. 2000 407 1-2 39 46 10.1016/S0014‑2999(00)00728‑7 11050288
    [Google Scholar]
  15. Caffrey M. HIV envelope: challenges and opportunities for development of entry inhibitors. Trends Microbiol. 2011 19 4 191 197 10.1016/j.tim.2011.02.001 21377881
    [Google Scholar]
  16. Shankar E.M. Vignesh R. HIVeMycobacterium tuberculosis co-infection: a ‘danger-couple model’of disease pathogenesis. Pathog. Dis. 2014 70 110 118 10.1111/2049‑632X.12108 24214523
    [Google Scholar]
  17. Montesano F. Barlocco D. Piaz V.D. Leonardi A. Poggesi E. Fanelli F. De Benedetti P.G. Isoxazolo-[3,4-d]-pyridazin-7-(6H)-ones and their corresponding 4,5-disubstituted-3-(2H)-pyridazinone analogues as new substrates for alpha1-adrenoceptor selective antagonists: synthesis, modeling, and binding studies. Bioorg. Med. Chem. 1998 6 7 925 935 10.1016/S0968‑0896(98)00056‑X 9730228
    [Google Scholar]
  18. Diaz C.A. Allocco J. Powles M.A. Yeung L. Donald R.G.K. Anderson J.W. Liberator P.A. Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): Antiparasitic activity of a PKG inhibitor. Mol. Biochem. Parasitol. 2006 146 1 78 88 10.1016/j.molbiopara.2005.10.020 16325279
    [Google Scholar]
  19. Kahrilas P.J. Dent J. Lauritsen K. Malfertheiner P. Denison H. Franzén S. Hasselgren G. A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis. Clin. Gastroenterol. Hepatol. 2007 5 12 1385 1391 10.1016/j.cgh.2007.08.014 17950677
    [Google Scholar]
  20. Bessis A.S. Acher F. Bertrand H-O. Galvez T. De Colle C. Pin J-P. Three‐dimensional model of the extracellular domain of the type 4a metabotropic glutamate receptor: New insights into the activation process. Protein Sci. 2000 9 11 2200 2209 10.1110/ps.9.11.2200 11152130
    [Google Scholar]
  21. Das T.M. Rao C.P. Kalle N. Synthesis and crystallographic characterization of some derivatives of benzimidazole. Indian J. Chem. 2003 42B 661 665
    [Google Scholar]
  22. Pękala E. Stadnicka K. Broda A. Zygmunt M. Filipek B. Kieć-Kononowicz K. Synthesis, structure–activity relationship of some new anti-arrhythmic 5-arylidene imidazolidine-2,4-dione derivatives. Eur. J. Med. Chem. 2005 40 3 259 269 10.1016/j.ejmech.2004.11.006 15725495
    [Google Scholar]
  23. Oh K. Murofushi N. Design and synthesis of novel imidazole derivatives as potent inhibitors of allene oxide synthase(CYP74). Bioorg. Med. Chem. 2002 10 12 3707 3711 10.1016/S0968‑0896(02)00422‑4 12413826
    [Google Scholar]
  24. Sinicropi M.S. Tavani C. Rosano C. Ceramella J. Iacopetta D. Barbarossa A. Bianchi L. Benzi A. Maccagno M. Ponassi M. Spinelli D. Petrillo G. A Nitrocarbazole as a New Microtubule-Targeting Agent in Breast Cancer Treatment. Appl. Sci. (Basel) 2021 11 19 9139 10.3390/app11199139
    [Google Scholar]
  25. Yakkala P.A. Penumallu N.R. Shafi S. Kamal A. Prospects of topoisomerase inhibitors as promising anti-cancer agents. Pharmaceuticals 2023 16 10 1456 10.3390/ph16101456 37895927
    [Google Scholar]
  26. Ayyamperumal S. Dj D. Tallapaneni V. Mohan S. S B. Selvaraj J. Joghee N.M. Mjn C. Molecular docking analysis of α-Topoisomerase II with δ-Carboline derivatives as potential anticancer agents. Bioinformation 2021 17 1 249 265 10.6026/97320630017249 34393444
    [Google Scholar]
  27. Kalirajan R. Sankar S. Jubie S. Gowramma B. Molecular Docking studies and in-silico ADMET Screening of Some novel Oxazine substituted 9-Anilinoacridines as Topoisomerase II Inhibitors. Indian Journal of Pharmaceutical Education and Research 2017
    [Google Scholar]
  28. Gupta A. Singh P. Kamble B. Kulkarni A. Joghee Nanjan Chandrasekar M. Synthesis, Docking and Biological Evaluation of Some Novel 5-bromo-2- (5-aryl-1,3,4-thiadiazol-2-yl)isoindoline-1,3-dione Derivatives Targeting ATP-binding Site of Topoisomerase II. Lett. Drug Des. Discov. 2012 9 7 668 675 10.2174/157018012801319463
    [Google Scholar]
/content/journals/cei/10.2174/0115734080340941241002051637
Loading
In vitro and In Silico Molecular Modeling Studies of Newly Synthesized Pyrrole Derivatives for their Antimicrobial and Anticancer Properties
Bentham Science Publishers ; https://doi.org/10.2174/0115734080340941241002051637
/content/journals/cei/10.2174/0115734080340941241002051637
/content/journals/cei/10.2174/0115734080340941241002051637
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: pyrroles ; antimicrobial ; Pyrazole ; MCF-07 ; Heterocyclic ; Anticancer

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test